Cited by 168Genetic Neurodegenerative DiseasesDementia and Cognitive Impairment ResearchHealth Systems, Economic Evaluations, Quality of Life

The DOI matches its Crossref record; 283 of the 290 references it cites were found in a registry or an index.

A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases

Open access

Paulsen, Jane S., Nance, Martha, Kim, Ji-In, Carlozzi, Noelle E., Panegyres, Peter K., Erwin, Cheryl, Goh, Anita, McCusker, Elizabeth, Williams, Janet K.·2013·Progress in Neurobiology

DOI 10.1016/j.pneurobio.2013.08.003PMC PMC3833259

Open this paper in CoChat — free account

Abstract

The past decade has witnessed an explosion of evidence suggesting that many neurodegenerative diseases can be detected years, if not decades, earlier than previously thought. To date, these scientific advances have not provoked any parallel translational or clinical improvements. There is an urgency to capitalize on this momentum so earlier detection of disease can be more readily translated into improved health-related quality of life for families at risk for, or suffering with, neurodegenerative diseases. In this review, we discuss health-related quality of life (HRQOL) measurement in neurodegenerative diseases and the importance of these "patient reported outcomes" for all clinical research. Next, we address HRQOL following early identification or predictive genetic testing in some neurodegenerative diseases: Huntington disease, Alzheimer's disease, Parkinson's disease, Dementia with Lewy bodies, frontotemporal dementia, amyotrophic lateral sclerosis, prion diseases, hereditary ataxias, Dentatorubral-pallidoluysian atrophy and Wilson's disease. After a brief report of available direct-to-consumer genetic tests, we address the juxtaposition of earlier disease identification with assumed reluctance toward predictive genetic testing. Forty-one studies examining health-related outcomes following predictive genetic testing for neurodegenerative disease suggested that (a) extreme or catastrophic outcomes are rare; (b) consequences commonly include transiently increased anxiety and/or depression; (c) most participants report no regret; (d) many persons report extensive benefits to receiving genetic information; and (e) stigmatization and discrimination for genetic diseases are poorly understood and policy and laws are needed. Caution is appropriate for earlier identification of neurodegenerative diseases but findings suggest further progress is safe, feasible and likely to advance clinical care.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.pneurobio.2013.08.003

Cites

283 of 283 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Principles of Biomedical Ethics
(2012) · Thieves of Virtue · doi:10.7551/mitpress/9079.003.0009 · Cited by 13,453
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Finding the missing heritability of complex diseases
Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., McCarthy, M. I., Ramos, E. M., Cardon, L. R., Chakravarti, A., et al. (2009) · Nature · doi:10.1038/nature08494 · Cited by 8,336
The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008
Cella, D., Riley, W., Stone, A., Rothrock, N., Reeve, B., Yount, S., Amtmann, D., Bode, R., Buysse, D., Choi, S., et al. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.011 · Cited by 5,128
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
The Sickness Impact Profile: Development and Final Revision of a Health Status Measure
Bergner, M., Bobbitt, R. A., Carter, W. B., & Gilson, B. S. (1981) · Medical Care · doi:10.1097/00005650-198108000-00001 · Cited by 4,619
Classificação Internacional de Funcionalidade (CIF)
Battistella, L. R., & de Brito, C. M. M. (2002) · Acta Fisiátrica · doi:10.5935/0104-7795.20020003 · Cited by 4,470
Untitled work
(1994) · Medical Entomology and Zoology · Cited by 4,156

Show all 290 references

Research works printed but not linked: 6

Cassidy, 2008, Comparing test-specific distress of susceptibility versus deterministic genetic testing for Alzheimer's disease, Alzheimer's Dementia: J. Alzheimer's Assoc., 4, 406, 10.1016/j.jalz.2008.04.007 · DOI
Cella, 2010, The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008, J. Clin. Epidemiol., 63, 1179, 10.1016/j.jclinepi.2010.04.011 · DOI · Paper page
Huntington, 1872, On chorea, Med. Surg. Rep. Phila., 26, 317
Patrick, 1988, What constitutes quality of life?. Concepts and dimensions, Clin. Nutr., 7, 53
Rothstein, 2007, Genetic Information Nondiscirimination Act is a first step; won’t solve the problem, CCH Labor Law Rep., 950
Wahlin, 1998, Reactions to predictive testing in Huntington disease: case reports of coping with a new genetic status, Am. J. Med. Genet., 73, 356, 10.1002/(SICI)1096-8628(19971219)73:3<356::AID-AJMG24>3.0.CO;2-H · DOI

Sorted by citations

Biomarkers of aging
Bao, H., Cao, J., Chen, M., Min, C., Chen, W., Chen, X., Chen, Y., Chen, Y., Chen, Y., Chen, Z., et al. (2023) · Science China Life Sciences · doi:10.1007/s11427-023-2305-0 · Cited by 402
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
Lewczuk, P., Riederer, P. F., O’Bryant, S. E., Verbeek, M. M., Dubois, B., Visser, P. J., Jellinger, K. A., Engelborghs, S., Ramírez, A., Parnetti, L., et al. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1375556 · Cited by 318
Depression in neurodegenerative diseases: Common mechanisms and current treatment options
Galts, C., Bettio, L. E. B., Jewett, D. C., Yang, C. C., Brocardo, P. S., Rodrigues, A. L. S., Thacker, J. S., & Gil‐Mohapel, J. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.04.002 · Cited by 278
Multi-modality machine learning predicting Parkinson’s disease
Makarious, M. B., Leonard, H. L., Vitale, D., Iwaki, H., Sargent, L. J., Dadu, A., Violich, I., Hutchins, E. D., Saffo, D., Bandrés‐Ciga, S., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00288-w · Cited by 194
Self-citation
The Patterns of Inheritance in Early-Onset Dementia
Jarmolowicz, A. I., Chen, H.-Y., & Panegyres, P. K. (2014) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317514545825 · Cited by 91
Self-citation
Cognitive and behavioral changes in Huntington disease before diagnosis
Paulsen, J. S., Miller, A. C., Hayes, T., & Shaw, E. E. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-12-801893-4.00006-7 · Cited by 83
Self-citation
Epidemiology of mucopolysaccharidoses (MPS) in United States: challenges and opportunities
Puckett, Y., Mallorga-Hernández, A., & Montaño, A. M. (2021) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-021-01880-8 · Cited by 73
The Value of Diagnostic Information in Personalised Healthcare: A Comprehensive Concept to Facilitate Bringing This Technology into Healthcare Systems
Wurcel, V., Cicchetti, A., Garrison, L. P., Kip, M. M. A., Koffijberg, H., Kolbe, A., Leeflang, M., Merlin, T., Mestre‐Ferrandiz, J., Oortwijn, W., et al. (2019) · Public Health Genomics · doi:10.1159/000501832 · Cited by 76
Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials
Kim, S. Y. H., Karlawish, J. H., & Berkman, B. E. (2015) · Neurology · doi:10.1212/wnl.0000000000001451 · Cited by 70
A clinical classification acknowledging neuropsychiatric and cognitive impairment in Huntington’s disease
Vinther‐Jensen, T., Larsen, I. U., Hjermind, L. E., Budtz–Jørgensen, E., Nielsen, T. T., Nørremølle, A., Nielsen, J. E., & Vogel, A. (2014) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-014-0114-8 · Cited by 69
Considerations regarding a diagnosis of Alzheimer’s disease before dementia: a systematic review
van der Schaar, J., Visser, L. N. C., Bouwman, F. H., Ket, J. C. F., Scheltens, P., Bredenoord, A. L., & van der Flier, W. M. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-00971-3 · Cited by 74
Tetramethylpyrazine inhibits CoCl2‐induced neurotoxicity through enhancement of Nrf2/GCLc/GSH and suppression of HIF1α/NOX2/ROS pathways
Guan, D., Su, Y., Li, Y., Wu, C., Yi, M., Peng, X., & Cui, Y. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13161 · Cited by 66
Onset of Huntington's disease: Can it be purely cognitive?
Paulsen, J. S., & Long, J. D. (2014) · Movement Disorders · doi:10.1002/mds.25997 · Cited by 63
Self-citation
Pioglitazone attenuates lipopolysaccharide-induced depression-like behaviors, modulates NF-κB/IL-6/STAT3, CREB/BDNF pathways and central serotonergic neurotransmission in mice
Liao, L., Zhang, X. D., Li, J., Zhang, Z. W., Yang, C., Rao, C., Zhou, C., Zeng, L., Zhao, L., Fang, L., et al. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.05.036 · Cited by 63
Lycium barbarum polysaccharide protects against neurotoxicity via the Nrf2‑HO‑1 pathway
Cao, S., Du, J., & Hei, Q. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5127 · Cited by 63
Exposure to Ambient Air Particles Increases the Risk of Mental Disorder: Findings from a Natural Experiment in Beijing
Jia, Z., Wei, Y., Li, X., Yang, L., Liu, H., Guo, C., Zhang, L., Li, N., Guo, S., Qian, Y., et al. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15010160 · Cited by 62
P5 eHealth: An Agenda for the Health Technologies of the Future
Pravettoni, G., & Triberti, S. (2019) · Springer eBooks · doi:10.1007/978-3-030-27994-3 · Cited by 63
HDQLIFE: development and assessment of health-related quality of life in Huntington disease (HD)
Carlozzi, N. E., Schilling, S. G., Lai, J., Paulsen, J. S., Hahn, E. A., Perlmutter, J. S., Ross, C. A., Downing, N. R., Kratz, A. L., McCormack, M. K., et al. (2016) · Quality of Life Research · doi:10.1007/s11136-016-1386-3 · Cited by 58
Self-citation
Quality of Life in Patients with Neurodegenerative Diseases
Batista, P., & Pereira, A. (2016) · Journal of Neurology and Neuroscience · doi:10.21767/2171-6625.100074 · Cited by 56
MicroSweat: A wearable microfluidic patch for noninvasive and reliable sweat collection enables human stress monitoring
Shajari, S., Salahandish, R., Zare, A., Hassani, M., Moossavi, S., Munro, E., Rashid, R., Rosenegger, D., Bains, J. S., & Sanati Nezhad, A. (2023) · Advanced Science · doi:10.1002/advs.202204171 · Cited by 55
Patients' views on the ethical challenges of early Parkinson disease detection
Schaeffer, E., Rogge, A., Nieding, K., Helmker, V., Letsch, C., Hauptmann, B., & Berg, D. (2020) · Neurology · doi:10.1212/wnl.0000000000009400 · Cited by 49
Towards Modern-Age Advanced Sensors for the Management of Neurodegenerative Disorders: Current Status, Challenges and Prospects
Gautam, A. (2022) · ECS Sensors Plus · doi:10.1149/2754-2726/ac973e · Cited by 50
Genetic Testing and Counseling in the Diagnosis and Management of Young-Onset Dementias
Goldman, J. S. (2015) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2015.01.008 · Cited by 52
Plasma Cystatin C and High-Density Lipoprotein Are Important Biomarkers of Alzheimer’s Disease and Vascular Dementia: A Cross-Sectional Study
Wang, R., Chen, Z., Fu, Y., Wei, X., Liao, J., Liu, X., He, B., Xu, Y., Zou, J., Yang, X., et al. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00026 · Cited by 50
Emerging roles for high‐density lipoproteins in neurodegenerative disorders
Bahrami, A., Barreto, G. E., Lombardi, G., Pirro, M., & Sahebkar, A. (2019) · BioFactors · doi:10.1002/biof.1541 · Cited by 50
siRNA Therapeutics: Future Promise for Neurodegenerative Diseases
Amiri, A., Barreto, G. E., Sathyapalan, T., & Sahebkar, A. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210402104054 · Cited by 46
Predictive genetic testing for amyotrophic lateral sclerosis and frontotemporal dementia: genetic counselling considerations
Crook, A., Williams, K. L., Adams, L., Blair, I. P., & Rowe, D. B. (2017) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2017.1332079 · Cited by 44
Application of Nanomedicine to the CNS Diseases
Carradori, D., Gaudin, A., Brambilla, D., & Andrieux, K. (2016) · International review of neurobiology · doi:10.1016/bs.irn.2016.06.002 · Cited by 39
Tantalizing role of p53 molecular pathways and its coherent medications in neurodegenerative diseases
Talebi, M., Talebi, M., Kakouri, E., Farkhondeh, T., Pourbagher‐Shahri, A. M., Tarantilis, P. Α., & Samarghandian, S. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.01.042 · Cited by 42
Risk Disclosure in Prodromal Parkinson's Disease
Schaeffer, E., Toedt, I., Köhler, S., Rogge, A., & Berg, D. (2021) · Movement Disorders · doi:10.1002/mds.28723 · Cited by 37
Cost-Utility of Using Alzheimer’s Disease Biomarkers in Cerebrospinal Fluid to Predict Progression from Mild Cognitive Impairment to Dementia
Handels, R. L. H., Wimo, A. B., Dodel, R. C., Kramberger, M. G., Visser, P. J., Molinuevo, J. L., Verhey, F. R. J., & Winblad, B. G. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170324 · Cited by 39
Next Generation Sequencing Analysis in Early Onset Dementia Patients
Bonvicini, C., Initiative, A. D. N., Scassellati, C., Benussi, L., Maria, E. D., Maj, C., Ciani, M., Fostinelli, S., Mega, A., Bocchetta, M., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180482 · Cited by 37
Genetic counseling for prion disease: Updates and best practices
Goldman, J. S., & Vallabh, S. M. (2022) · Genetics in Medicine · doi:10.1016/j.gim.2022.06.003 · Cited by 37
Development of Neurodegenerative Disease Diagnosis and Monitoring from Traditional to Digital Biomarkers
Song, J., Cho, E., Lee, H., Lee, S., Kim, S., & Kim, J. (2025) · Biosensors · doi:10.3390/bios15020102 · Cited by 38
Self-citation
Understanding the Outcomes Measures used in Huntington Disease Pharmacological Trials: A Systematic Review
Carlozzi, N. E., Miciura, A. L., Migliore, N., & Dayalu, P. (2014) · Journal of Huntington s Disease · doi:10.3233/jhd-140115 · Cited by 34
Self-citation
Computer Aided Drug Design Studies in the Discovery of Secondary Metabolites Targeted Against Age-Related Neurodegenerative Diseases
Scotti, L., & Scotti, L. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150610143510 · Cited by 33
Mitomycin-treated undifferentiated embryonic stem cells as a safe and effective therapeutic strategy in a mouse model of Parkinson’s disease
Acquarone, M., de Melo, T. M., Meireles, F., Brito‐Moreira, J., de Oliveira, G. M., Ferreira, S. T., Castro, N. G., Tovar-Moll, F. F., Houzel, J., & Rehen, S. K. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00097 · Cited by 32
Ethical Implications of Alzheimer’s Disease Prediction in Asymptomatic Individuals through Artificial Intelligence
Ursin, F., Timmermann, C., & Steger, F. (2021) · Diagnostics · doi:10.3390/diagnostics11030440 · Cited by 38
Activation of TrkB-Akt signaling rescues deficits in a mouse model of SCA6
Cook, A. A., Jayabal, S., Sheng, J., Fields, E., Leung, T. C. S., Quilez, S., McNicholas, E., Lau, L., Huang, S., & Watt, A. J. (2022) · Science Advances · doi:10.1126/sciadv.abh3260 · Cited by 32
The Many Facets of Unawareness in Huntington Disease
McCusker, E. A., & Loy, C. T. (2014) · PubMed Central · doi:10.7916/d8fj2fd3 · Cited by 31
Self-citation
The Arch Electrode: A Novel Dry Electrode Concept for Improved Wearing Comfort
Vasconcelos, B., Fiedler, P., Machts, R., Haueisen, J., & Fonseca, C. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.748100 · Cited by 30
Quality of life of patients with Parkinson's disease and neurodegenerative dementia: A nationally representative study
Chekani, F., Bali, V., & Aparasu, R. R. (2015) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2015.09.007 · Cited by 30
Science and Suffering: Genetics and the Lived Experience of Illness
Halpin, M. (2017) · Social Problems · doi:10.1093/socpro/spw057 · Cited by 28
Patient and Relative Experiences and Decision-making About Genetic Testing and Counseling for Familial ALS and FTD
Crook, A., Jacobs, C., Newton-John, T. R. O., Richardson, E., & McEwen, A. (2021) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000458 · Cited by 27
Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington’s disease
Birolini, G., Valenza, M., Ottonelli, I., Talpo, F., Minoli, L., Cappelleri, A., Bombaci, M., Caccia, C., Canevari, C., Trucco, A., et al. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106823 · Cited by 28
Ethical Considerations in Screening for Rapid Eye Movement Sleep Behavior Disorder in the General Population
Dommershuijsen, L. J., Darweesh, S. K. L., Luik, A. I., Kieboom, B. C. T., Koudstaal, P. J., Boon, A. J. W., Ikram, M. A., Ikram, M. K., & Bunnik, E. M. (2020) · Movement Disorders · doi:10.1002/mds.28262 · Cited by 25
Biomarker-Based Risk Prediction of Alzheimer’s Disease Dementia in Mild Cognitive Impairment: Psychosocial, Ethical, and Legal Aspects
Rostamzadeh, A., Schwegler, C., Gil‐Navarro, S., Rosende‐Roca, M., Romotzky, V., Ortega, G., Cañabate, P., Moreno, M., Schmitz‐Luhn, B., Boada, M., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-200484 · Cited by 25
Genetic and Transcriptomic Biomarkers in Neurodegenerative Diseases: Current Situation and the Road Ahead
Lake, J., Storm, C. S., Makarious, M. B., & Bandrés‐Ciga, S. (2021) · Cells · doi:10.3390/cells10051030 · Cited by 24
The Views of Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder on Risk Disclosure
Pérez‐Carbonell, L., Simonet, C., Chohan, H., Gill, A., Leschziner, G. D., Schrag, A. E., & Noyce, A. J. (2023) · Movement Disorders · doi:10.1002/mds.29403 · Cited by 24
Exosome-mediated therapeutic delivery: A new horizon for human neurodegenerative disorders’ treatment (with a focus on siRNA delivery improvement)
Seyfizadeh, N., Seyfizadeh, N., Borzoueisileh, S., Elahimanesh, F., Hosseini, V., & Nouri, M. (2019) · Process Biochemistry · doi:10.1016/j.procbio.2019.06.025 · Cited by 24
Predictive Precision Medicine: Towards the Computational Challenge
Tuena, C., Semonella, M., Fernández‐Álvarez, J., Colombo, D., & Cipresso, P. (2019) · Springer eBooks · doi:10.1007/978-3-030-27994-3_5 · Cited by 23
Communicating 5-Year Risk of Alzheimer’s Disease Dementia: Development and Evaluation of Materials that Incorporate Multiple Genetic and Biomarker Research Results
Mozersky, J. T., Hartz, S. M., Linnenbringer, E. L., Levin, L., Streitz, M. L., Stock, K., Moulder, K. L., & Morris, J. C. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200993 · Cited by 24
Into the Prodrome: Diagnosis, Disadvantage, and Biomedical Ambiguity
Halpin, M. (2020) · Society and Mental Health · doi:10.1177/2156869320912456 · Cited by 21
Health-Related Quality of Life Assessment in Children Followed in a Cardiomyopathy Clinic
Friess, M. R., Marino, B. S., Cassedy, A. E., Wilmot, I., Jefferies, J. L., & Lorts, A. (2014) · Pediatric Cardiology · doi:10.1007/s00246-014-1042-z · Cited by 21
The herbal extract KCHO-1 exerts a neuroprotective effect by ameliorating oxidative stress via heme oxygenase-1 upregulation
Lee, D., Ko, W., Song, B.-K., Son, I., Kim, D.-W., Kang, D. G., Lee, H.-S., Oh, H., Jang, J., Kim, Y.-E., et al. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5129 · Cited by 21
A novel pyrazole-containing selenium compound modulates the oxidative and nitrergic pathways to reverse the depression-pain syndrome in mice
Birmann, P. T., Casaril, A. M., Hartwig, D., Jacob, R. G., Seixas, F. K., Collares, T. V., & Savegnago, L. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146880 · Cited by 21
Ethical issues in susceptibility genetic testing for late‐onset neurodegenerative diseases
de Lara, A. M., Soto‐Gómez, L., Núñez‐Acosta, E., Zavala, G. S., & Rentería, M. E. (2018) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32699 · Cited by 21
Optimizing Parkinson’s Disease Prediction: A Comparative Analysis of Data Aggregation Methods Using Multiple Voice Recordings via an Automated Artificial Intelligence Pipeline
Yang, Z., Zhou, H., Srivastav, S., Shaffer, J. G., Abraham, K. T., Naandam, S. M., & Kakraba, S. (2025) · Data · doi:10.3390/data10010004 · Cited by 22
Managing Ethical Dilemmas in End-Stage Neurodegenerative Diseases
Low, J., & Ho, E. P. Y. (2017) · Geriatrics · doi:10.3390/geriatrics2010008 · Cited by 20
Prospective Evaluation of Predictive DNA Testing for Huntington's Disease in a Large German Center
Ibisler, A., Ocklenburg, S., Stemmler, S., Arning, L., Epplen, J. T., Carsten Saft, C., & Hoffjan, S. (2017) · Journal of Genetic Counseling · doi:10.1007/s10897-017-0085-8 · Cited by 20
Psychological Impact of Predictive Genetic Testing in VCP Inclusion Body Myopathy, Paget Disease of Bone and Frontotemporal Dementia
Surampalli, A., Khare, M., Kubrussi, G., Wencel, M., Tanaja, J., Donkervoort, S. C., Osann, K., Simon, M. T., Wallace, D. C., Smith, C. D., et al. (2015) · Journal of Genetic Counseling · doi:10.1007/s10897-015-9819-7 · Cited by 20
Phosphatidylserine: An overview on functionality, processing techniques, patents, and prospects
Chen, J., Li, J., Xu, H., Li, J., Yuan, Y., Xu, X., & Bi, Y. (2023) · Grain & Oil Science and Technology · doi:10.1016/j.gaost.2023.11.001 · Cited by 19
Reprogramming of HUVECs into Induced Pluripotent Stem Cells (HiPSCs), Generation and Characterization of HiPSC-Derived Neurons and Astrocytes
Haile, Y. G., Nakhaei‐Nejad, M., Boakye, P. A., Baker, G. B., Smith, P. A., Murray, A. G., Giuliani, F., & Jahroudi, N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119617 · Cited by 19
Reconceptualizing Harms and Benefits in the Genomic Age
Prince, A. E. R., & Berkman, B. E. (2018) · Personalized Medicine · doi:10.2217/pme-2018-0022 · Cited by 19
Genetic Testing in Prion Disease: Psychological Consequences of the Decisions to Know or Not to Know
Schwartz, M., Brandel, J., Babonneau, M.-L., Boucher, C., Schaerer, É., Haı̈k, S., Laplanche, J., Gargiulo, M., & Dürr, A. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00895 · Cited by 18
omicSynth: An open multi-omic community resource for identifying druggable targets across neurodegenerative diseases
Alvarado, C. X., Makarious, M. B., Weller, C. A., Vitale, D., Koretsky, M. J., Bandrés‐Ciga, S., Iwaki, H., Levine, K. S., Singleton, A., Faghri, F., et al. (2024) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2023.12.006 · Cited by 19
Lipid Oxidation at the Crossroads: Oxidative Stress and Neurodegeneration Explored in Caenorhabditis elegans
Tortajada-Pérez, J., Carranza, A. D. V., Río, C. T.-D., Collado-Pérez, M., Millán, J. M., García‐García, G., & Vázquez‐Manrique, R. P. (2025) · Antioxidants · doi:10.3390/antiox14010078 · Cited by 19
HD-PRO-TRIAD™ Validation: A Patient-reported Instrument for the Symptom Triad of Huntington’s Disease
Carlozzi, N. E., Victorson, D. E., Sung, V., Beaumont, J. L., Cheng, W. Y., Gorin, B., Duh, M. S., Samuelson, D., Tulsky, D. S., Gutiérrez, S., et al. (2014) · Europe PMC (PubMed Central) · doi:10.7916/d8pn93nz · Cited by 18
Self-citation
People's interest in brain health testing: Findings from an international, online cross-sectional survey
Carver, R. B., Fredheim, N. A. G., Mowinckel, A. M., Ebmeier, K. P., Friedman, B. B., Rosness, T. A., Drevon, C. A., Suri, S., Baaré, W. F. C., Zsoldos, E., et al. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.998302 · Cited by 17
Identification of Prodromal Parkinson Disease
Rees, R. N., Noyce, A. J., & Schrag, A. E. (2024) · Neurology · doi:10.1212/wnl.0000000000209394 · Cited by 18
Parkinsons Detection from Gait Time Series Classification Using Modified Metaheuristic Optimized Long Short Term Memory
Marković, F. N., Jovanović, L., Spalević, P., Kaljević, J., Zivkovic, M. Z., Šimić, V., Shaker, H., & Bačanin, N. (2025) · Neural Processing Letters · doi:10.1007/s11063-025-11735-z · Cited by 20
Understanding domains that influence perceived stigma in individuals with Huntington disease.
Boileau, N. R., Paulsen, J. S., Ready, R. E., Hahn, E. A., Lai, J., & Carlozzi, N. E. (2020) · Rehabilitation Psychology · doi:10.1037/rep0000311 · Cited by 16
Self-citation
The lived experience of reconstructing identity in response to genetic risk of frontotemporal degeneration and amyotrophic lateral sclerosis
Dratch, L., Owczarzak, J., Mu, W., Cousins, K. A. Q., Massimo, L. M., Grossman, M., & Erby, L. H. (2023) · Journal of Genetic Counseling · doi:10.1002/jgc4.1749 · Cited by 15
What ARE Parkinson disease? Non-motor features transform conception of the shaking palsy
Jain, S., & Goldstein, D. S. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.04.013 · Cited by 15
Perceptions of the impact of chorea on health-related quality of life in Huntington disease (HD): A qualitative analysis of individuals across the HD spectrum, family members, and clinicians
Sherman, C. W., Iyer, R. G., Abler, V., Antonelli, A., & Carlozzi, N. E. (2019) · Neuropsychological Rehabilitation · doi:10.1080/09602011.2018.1564675 · Cited by 14
Self-citation
Perspectives of People At-Risk on Parkinson’s Prevention Research
Keavney, J. L., Mathur, S., Schroeder, K., Merrell, R., Castillo‐Torres, S. A., Gao, V., Crotty, G. F., Schwarzschild, M. A., & Poma, J. M. (2024) · Journal of Parkinson s Disease · doi:10.3233/jpd-230436 · Cited by 13
A New Approach to Assessing Affect and the Emotional Implications of Personal Genomic Testing for Common Disease Risk
O’Neill, S. C., Tercyak, K. P., Baytop, C., Alford, S. H., & McBride, C. M. (2015) · Public Health Genomics · doi:10.1159/000370101 · Cited by 14
“I have to start learning how to live with becoming sick”: A scoping review of the lived experiences of people with Huntington's disease
Mahmood, S., Law, S., & Bombard, Y. (2021) · Clinical Genetics · doi:10.1111/cge.14024 · Cited by 14
Identifying Motor, Emotional–Behavioral, and Cognitive Deficits that Comprise the Triad of HD Symptoms from Patient, Caregiver, and Provider Perspectives
Victorson, D. E., Carlozzi, N. E., Frank, S., Beaumont, J. L., Cheng, W. Y., Gorin, B., Duh, M. S., Samuelson, D., Tulsky, D. S., Gutiérrez, S., et al. (2014) · Europe PMC (PubMed Central) · doi:10.7916/d8jw8bws · Cited by 14
Self-citation
Huntington Disease: The Complexities of Making and Disclosing a Clinical Diagnosis After Premanifest Genetic Testing
McCusker, E. A., & Loy, C. T. (2017) · PubMed Central · doi:10.7916/d8pk0tdd · Cited by 13
Self-citation
The Effect of Predictive Testing in Adult‐Onset Neurodegenerative Diseases on Social and Personal Life
Cohn‐Hokke, P. E., Swieten, J. C. V., Pijnenburg, Y. A. L., Tibben, A., Meijers-Heijboer, H. E. J., & Kievit, A. J. A. (2017) · Journal of Genetic Counseling · doi:10.1007/s10897-017-0195-3 · Cited by 15
Prodromes and Preclinical Detection of Brain Diseases: Surveying the Ethical Landscape of Predicting Brain Health
Ahlgrim, N. S., Garza, K. M., Hoffman, C. A., & Rommelfanger, K. S. (2019) · eNeuro · doi:10.1523/eneuro.0439-18.2019 · Cited by 16
A novel α-ketoamide reactivity-based two-photon fluorogenic probe for visualizing peroxynitrite in Parkinson’s disease models
Shao, T., Xu, X., Wang, L., Shen, Y., Zhao, J., Li, H., Zhang, D., Du, W., Bai, H., Peng, B., et al. (2022) · Journal of Innovative Optical Health Sciences · doi:10.1142/s1793545822500390 · Cited by 12
Direct-to-consumer tests advertised online in Australia and their implications for medical overuse: systematic online review and a typology of clinical utility
Shih, P., Ding, P., Carter, S. M., Stanaway, F., Horvath, A. R., Langguth, D., Saad, M., John, A. S., & Bell, K. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-074205 · Cited by 12
BrainNeXt: novel lightweight CNN model for the automated detection of brain disorders using MRI images
Poyraz, M., Poyraz, A. K., Doğan, Y., Gunes, S., Mir, H., Paul, J. K., Barua, P. D., Bayğın, M., Doğan, Ş., Tuncer, T., et al. (2025) · Cognitive Neurodynamics · doi:10.1007/s11571-025-10235-z · Cited by 12
The Clinical Spectrum of Young Onset Dementia Points to Its Stochastic Origins
Panegyres, P. K. (2021) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-210309 · Cited by 12
Self-citation
Implementation of a diagnostic decision aid for people with memory complaints and their general practitioners: a protocol of a before and after pilot trial
Linden, I., Wolfs, C. A. G., Perry, M., Metsemakers, J. F. M., van der Weijden, T., de Vugt, M. E., Verhey, F. R. J., Handels, R. L. H., Rikkert, M. G. M. O., Dirksen, C. D., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-049322 · Cited by 11
Unlocking Access to Broad Molecular Profiling: Benefits, Barriers, and Policy Solutions
Thomas, D. M., Hackett, J. M., & Pleština, S. (2021) · Public Health Genomics · doi:10.1159/000520000 · Cited by 11
Health survey of adults with hereditary spastic paraparesis compared to population study controls
Fjermestad, K. W., Kanavin, O. J., Næss, E. E., Hoxmark, L. B., & Hummelvoll, G. (2016) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-016-0469-0 · Cited by 11
Research Participant Interest in Learning Results of Biomarker Tests for Alzheimer Disease
Goswami, S., Hartz, S. M., Oliver, A., Jackson, S., Ogungbenle, T., Evans, A., Linnenbringer, E. L., Moulder, K. L., Morris, J. C., & Mozersky, J. T. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.2919 · Cited by 10
Impacts of apolipoprotein E disclosure on healthy Asian older adults: a cohort study
Sng, W. T., Yeo, S. N., Lin, X. B., & Lee, T.-S. W. (2019) · International Psychogeriatrics · doi:10.1017/s1041610218002089 · Cited by 10
Regulation of Superoxide by BAP31 through Its Effect on p22phox and Keap1/Nrf2/HO‐1 Signaling Pathway in Microglia
Liu, X., Yuan, Q., Li, G., Jia, C., Liu, J., Yang, Y., Wang, X., Hou, Y., & Wang, B. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/1457089 · Cited by 11
Ethical Issues Raised by Epigenetic Testing for Alcohol, Tobacco, and Cannabis
Erwin, C. J. (2015) · Behavioral Sciences & the Law · doi:10.1002/bsl.2204 · Cited by 10
Self-citation
Completed Suicide in An Autopsy-Confirmed Case of Early Onset Alzheimer’s Disease
Hartzell, J. W., Geary, R., Gyure, K. A., Chivukula, V. R., & Haut, M. W. (2018) · Neurodegenerative Disease Management · doi:10.2217/nmt-2017-0045 · Cited by 9
Take the First-Person Perspective to Become Dementia-Friendly: The Use of 360° Video for Experiencing Everyday-Life Challenges With Cognitive Decline
Morganti, F., Palena, N., Savoldelli, P., & Greco, A. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.01117 · Cited by 9
Risk disclosure in prodromal Parkinson's disease – A survey of neurologists
Kayiş, G., Yılmaz, R., Arda, B., & Akbostancı, M. C. (2022) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2022.105240 · Cited by 9
Predictors of Workplace Disability in a Premanifest Huntington’s Disease Cohort
Goh, A. M. Y., You, E., Perin, S., Clay, F. J., Loi, S., Ellis, K., Chong, T., Ames, D., & Lautenschlager, N. (2018) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.17040086 · Cited by 8
Self-citation
A Systematic Review on Confidentiality, Disclosure, and Stigma in the United States: Lessons for HIV Care in Pregnancy From Reproductive Genetics
Wilkinson, B. E., & Arora, K. S. (2015) · The New Bioethics · doi:10.1179/2050287715z.00000000067 · Cited by 8
Prognoza: Parkinson’s Disease Prediction Using Classification Algorithms
Shivakoti, M., Medaramatla, S. C., Godavarthi, D., & Shivakoti, N. (2023) · EAI Endorsed Transactions on Pervasive Health and Technology · doi:10.4108/eetpht.9.3933 · Cited by 8
Individuals' experiences in genetic counseling and predictive testing for familial amyotrophic lateral sclerosis
Steigerwald, C. G., Bertolini, C., McElhiney, M. C., Bergner, A. L., Harms, M. B., & Harrington, E. A. (2024) · Journal of Genetic Counseling · doi:10.1002/jgc4.1890 · Cited by 8

Authors: Paulsen, J. S., Nance, M., Kim, J.-I., Carlozzi, N. E., Panegyres, P. K., Erwin, C., Goh, A., McCusker, E., & Williams, J. K.
Affiliations: University of Iowa (US)
Park Nicollet Methodist Hospital (US)
University of Michigan (US)
The University of Texas Health Science Center at Houston (US)
The Royal Melbourne Hospital (AU)
The University of Sydney (AU)
Corresponding author: Paulsen, Jane S.
ORCID: Paulsen, Jane S.
Nance, Martha
Carlozzi, Noelle E.
Panegyres, Peter K.
Erwin, Cheryl
Goh, Anita
Williams, Janet K.
Venue: Progress in Neurobiology
Publisher: Elsevier BV
Published: 2013-11
Volume: 110
Pages: 2-28
ISSN: 0301-0082 (ISSN-L)
DOI: 10.1016/j.pneurobio.2013.08.003
PMC: PMC3833259
OpenAlex: W1980542254
Cited by: 168
References: 290
Citations by year: 2026: 8 · 2025: 16 · 2024: 18 · 2023: 10 · 2022: 18 · 2021: 21 · 2020: 10 · 2019: 14 · 2018: 9 · 2017: 14 · 2016: 8 · 2015: 11 · 2014: 10
FWCI: 0.98
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Progress in Neurobiology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Iowa Research Online (The University of Iowa) (submittedVersion)
Funders: National Institutes of Health (UL1TR000442)
U.S. Public Health Service (NGHG003330)
National Human Genome Research Institute (R01HG003330)
National Institute of Neurological Disorders and Stroke (R01NS040068, R01NS077946, NS040068, R01NS054893, NS054893, NS077946)
National Center for Advancing Translational Sciences
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Keywords: health-related quality of life, predictive genetic testing, early diagnosis, neurodegenerative diseases, patient-reported outcomes, Huntington's disease, Alzheimer's disease, Parkinson's disease, dementia with Lewy bodies, frontotemporal dementia, amyotrophic lateral sclerosis, prion disease, hereditary ataxia, dentatorubral-pallidoluysian atrophy, Wilson's disease, direct-to-consumer genetic testing, regret, genetic discrimination, stigmatization
MeSH terms: Brain, Genetic Testing, Humans, Quality of Life, Neurodegenerative Diseases, Early Diagnosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks